Picture of Virpax Pharmaceuticals logo

VRPX — Virpax Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Virpax Pharmaceuticals Inc On March 15, Got Letter From Nasdaq That Co Has Regained Compliance With Listing Rule 5550(A)(2)

March 18 (Reuters) - Virpax Pharmaceuticals Inc
 VRPX.O :
    * VIRPAX PHARMACEUTICALS INC: ON MARCH 15, GOT LETTER FROM
NASDAQ
THAT CO HAS REGAINED COMPLIANCE WITH LISTING RULE 5550(A)(2)

Source text for Eikon:  ID:n0001213900-24-023188 
Further company coverage:  VRPX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Virpax Pharmaceuticals

See all news